Open AccessAutologous serum therapy in chronic urticaria: Old wine in a new bottle
Author(s) -
Anubha Bajaj,
Abir Saraswat,
Amitabh Kumar Upadhyay,
Rajetha Damisetty,
Sandipan Dhar
Publication year - 2008
Publication title -
indian journal of dermatology, venereology, and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/0378-6323.39691
Subject(s) - medicine , asymptomatic , group b , gastroenterology , surgery , chronic urticaria , cohort
Chronic urticaria (CU) is one of the most challenging and frustrating therapeutic problems faced by a dermatologist. A recent demonstration of abnormal type 1 reactions to intradermal autologous serum injections in some CU patients has led to the characterization of a new subgroup of "autoimmune chronic urticaria". This has rekindled interest in the age-old practice of autologous blood injections as a theoretically sound treatment option in these patients.